Genetics of Pulmonary Fibrosis

ABSTRACT

Identifying genetic determinants of pulmonary fibrosis is at an early stage of evolution. It is now well recognized that "pulmonary fibrosis" covers a broad range of lung diseases including most topically the idiopathic interstitial pneumonias that have been classified recently. Additionally, it is recognized that the diffuse lung diseases of children that may progress to fibrosis are quite different from those of adults. Defining clinical phenotype is an absolute prerequisite to precise identification of genetic determinants, and this is at least part of the reason why we understand relatively little of these genetic determinants to date.

In children, a number of mutations have been identified, particularly with regard to surfactant protein. In adults, families with idiopathic pulmonary fibrosis are being collected but there are no genetic data on these at this point. In sporadic disease, associations have been reported in early phase genes with disease predisposition and also, importantly, with disease severity: future studies will inevitably incorporate issues of severity of disease in analyses.

KEYWORDS

Genetics - diffuse lung disease - idiopathic pulmonary fibrosis

REFERENCES

• 1 American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.  Am J Respir Crit Care Med . 2002;  165 277-304
• 2 Wright J A, Pennington J E. Familial lymphoid interstitial pneumonitis.  J Pediatr . 1987;  111 638
• 3 Buchino J J, Keenan W J, Algren J T, Bove K E. Familial desquamative interstitial pneumonitis occurring in infants.  Am J Med Genet Suppl . 1987;  3 285-291
• 4 Tal A, Maor E, Bar-Ziv J, Gorodischer R. Fatal desquamative interstitial pneumonia in three infants siblings.  J Pediatr . 1984;  104 873-876
• 5 Canakis A M, Cutz E, Manson D, O'Brodovich H. Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease.  Am J Respir Crit Care Med . 2002;  165 1557-1565
• 6 Fan L L, Langston C. Pediatric interstitial lung disease: children are not small adults.  Am J Respir Crit Care Med . 2002;  165 1466-1467
• 7 Low R B. Bronchoalveolar lavage lipids in idiopathic pulmonary fibrosis.  Chest . 1989;  95 3-5
• 8 Wilsher M L, Hughes D A, Haslam P L. Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile.  Clin Exp Immunol . 1988;  73 117-122
• 9 Hughes D A, Haslam P L. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis.  Chest . 1989;  95 82-89
• 10 Amin R S, Wert S E, Baughman R P. et al . Surfactant protein deficiency in familial interstitial lung disease.  J Pediatr . 2001;  139 85-92
• 11 Karinch A M, deMello D E, Floros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans.  Biochem J . 1997;  321(pt 1) 39-47
• 12 Diangelo S, Lin Z, Wang G. et al . Novel, nonradioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles.  Dis Markers . 1999;  15 269-281
• 13 Lin Z, deMello D E, Batanian J R. et al . Aberrant SP-B mRNA in lung tissue of patients with congenital alveolar proteinosis (CAP).  Clin Genet . 2000;  57 359-369
• 14 Floros J, Veletza S V, Kotikalapudi P. et al . Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome.  Biochem J . 1995;  305(pt 2) 583-590
• 15 Lin Z, deMello D E, Wallot M, Floros J. An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4.  Mol Genet Metab . 1998;  64 25-35
• 16 Nogee L M, Wert S E, Proffit S A, Hull W M, Whitsett J A. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency.  Am J Respir Crit Care Med . 2000;  161(3 pt 1) 973-981
• 17 Nogee L M, Dunbar III E A, Wert S E, Askin F, Hamvas A, Whitsett J A. A mutation in the surfactant protein C gene associated with familial interstitial lung disease.  N Engl J Med . 2001;  344 573-579
• 18 Glasser S W, Korfhagen T R, Perme C M, Pilot-Matias T J, Kister S E, Whitsett J A. Two SP-C genes encoding human pulmonary surfactant proteolipid.  J Biol Chem . 1988;  263 10326-10331
• 19 Nogee L M, Dunbar III E A, Wert S E, Askin F, Hamvas A, Whitsett J A. A mutation in the surfactant protein C gene associated with familial interstitial lung disease.  N Engl J Med . 2001;  344 573-579
• 20 Nogee L M, Dunbar III E A, Wert S, Askin F, Hamvas A, Whitsett J A. Mutations in the surfactant protein C gene associated with interstitial lung disease.  Chest . 2002;  121(suppl 3) S20-S21
• 21 Marshall R P, Puddicombe A, Cookson W O, Laurent G J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom.  Thorax . 2000;  55 143-146
• 22 Bitterman P B, Rennard S I, Keogh B A. Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members.  N Engl J Med . 1986;  314 1343-1347
• 23 Peabody J W, Peabody Jr W J, Hayes E W, Hayes Jr W E. Idiopathic pulmonary fibrosis: its occurrence in identical twin sisters.  Dis Chest . 1950;  18 330-344
• 24 Bonanni P P, Frymoyer J W, Jacox R F. A family study of idiopathic pulmonary fibrosis: a possible dysproteinemic and genetically determined disease.  Am J Med . 1965;  39 411-421
• 25 Marney A, Lane K B, Phillips III A J, Riley D J, Loyd J E. Idiopathic pulmonary fibrosis can be an autosomal dominant trait in some families.  Chest . 2001;  120(suppl 1) S30
• 26 Wahidi M M, Speer M C, Steele M P, Brown K K, Schwarz M I, Schwartz D A. Familial pulmonary fibrosis in the United States.  Chest . 2002;  121(suppl 3) S30
• 27 Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland.  Thorax . 2002;  57 338-342
• 28 Thomas A Q, Lane K, Phillips III J. et al . Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred.  Am J Respir Crit Care Med . 2002;  165 1322-1328
• 29 Brantly M, Avila N A, Shotelersuk V, Lucero C, Huizing M, Gahl W A. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.  Chest . 2000;  117 129-136
• 30 Gahl W A, Brantly M, Kaiser-Kupfer M I. et al . Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome).  N Engl J Med . 1998;  338 1258-1264
• 31 Huizing M, Gahl W A. Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes.  Curr Mol Med . 2002;  2 451-467
• 32 Vassilakis D A, Sourvinos G, Spandidos D A, Siafakas N M, Bouros D. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med . 2000;  162(3 pt 1) 1115-1119
• 33 Mori M, Kida H, Morishita H. et al . Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis.  Am J Respir Cell Mol Biol . 2001;  24 398-404
• 34 Kunitake R, Kuwano K, Miyazaki H. et al . Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung diseases.  Eur Respir J . 1998;  12 920-925
• 35 Hojo S, Fujita J, Yamadori I. et al . Heterogeneous point mutations of the p53 gene in pulmonary fibrosis.  Eur Respir J . 1998;  12 1404-1408
• 36 Whyte M, Hubbard R, Meliconi R. et al . Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms.  Am J Respir Crit Care Med . 2000;  162(2 pt 1) 755-758
• 37 Hutyrova B, Pantelidis P, Drabek J. et al . Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med . 2002;  165 148-151
• 38 Pantelidis P, Fanning G C, Wells A U, Welsh K I, du Bois M R. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med . 2001;  163 1432-1436
• 39 Bouros D, Wells A U, Nicholson A G. et al . Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.  Am J Respir Crit Care Med . 2002;  165 1581-1586
• 40 Gilchrist F C, Bunn C, Foley P J. et al . Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP.  Genes Immun . 2001;  2 76-81
• 41 Arnett F C. HLA and autoimmunity in scleroderma (systemic sclerosis) [review].  Int Rev Immunol . 1995;  12 107-128
• 42 Kuwana M, Medsger Jr A T, Wright T M. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.  J Clin Invest . 1995;  96 586-596
• 43 Avila J J, Lympany P A, Pantelidis P, Welsh K I, Black C M, du Bois M R. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis.  Am J Respir Cell Mol Biol . 1999;  20 106-112
• 44 Renzoni E, Lympany P, Sestini P. et al . Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis.  Arthritis Rheum . 2000;  43 1633-1640